ISOLA THERAPEUTICS INC

MINNEAPOLIS, MINNESOTA 554101534

$1.20M
Total Contract Value
6 awards
First Award
Aug 24, 2022
Last Award
Aug 30, 2024
Business Size
small
CAGE Code
890E6

Top Industries (NAICS)

NAICS CodeObligationsAwards
541714$750K2
541715$455K4

Contract Awards

3 awards found

75A50123C00031
Department of Health and Human Services
$750K
Jul 11, 2023

R&D FOR ENDOBRONCHIAL LAVAGE (EBL) TO PREVENT AND TREAT LUNG DAMAGE FROM PULMONARY CHEMICAL AGENTS AOI #15: REDIRECT (REPURPOSING DRUGS IN RESPONSE TO CHEMICAL THREATS)

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75N91022C00018
Department of Health and Human Services
$55K
Feb 16, 2023

PHASE I -TOPIC 431 - DRUG DELIVERY BY ENDOESOPHAGEAL LAVAGE (EEL) TO TREAT ESOPHAGEAL CANCER

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75N91022C00018
Department of Health and Human Services
$400K
Aug 24, 2022

PHASE I -TOPIC 431 - DRUG DELIVERY BY ENDOESOPHAGEAL LAVAGE (EEL) TO TREAT ESOPHAGEAL CANCER

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2022

Business Details

UEI
M3QDM72NME75
CAGE Code
890E6
Address
4408 WASHBURN AVE S
MINNEAPOLIS, MN 554101534
Congressional District
MN-05

Parent Company

ISOLA THERAPEUTICS INC

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov